GL1X · GenesisL1 explorer

MolNFT v1 · #2643 · protein

New insights into inhibitor design from the crystal structure and NMR studies of E. COLI gar transformylase in complex with beta-gar and 10-formyl-5,8,10-trideazafolic acid.

1C2T · Glycinamide ribonucleotide transformylase: “New insights into inhibitor design from the crystal structure and NMR studies of E. COLI gar transformylase…”. X-ray diffraction, 2 ligands (NHS, GAR), 4 pockets (best druggability 0.68).…

PDB
1C2T
Type
protein
Length
418 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycinamide ribonucleotide transformylase
EC
2.1.2.2
UniProt
P08179
Ligands
NHS, GAR
Pockets
4 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGlycinamide ribonucleotide transformylase (EC 2.1.2.2)protein20935% helix, 25% strandP08179

Ligands and binding sites

  • NHS · 10-formyl-5,8,10-trideazafolic acid · ligand · 2 copies · chains A, B
  • GAR · Glycinamide ribonucleotide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13560.680.8137NHS, GAR
23440.650.8037NHS, GAR
33370.630.7938empty
4650.360.7720empty

Interfaces

1 interface between chains.

  • A–B · 281 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 1C2T · New insights into inhibitor design from the crystal structure and NMR studies of E. COLI… · the same entry in another collection · chain A against A, TM-score 1.00
  • P08179 · AlphaFold monomer V2.0 prediction for phosphoribosylglycinamide formyltransferase (P08179) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.